# Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALL

> **NCT05350852** · PHASE1 · UNKNOWN · sponsor: **Zhejiang University** · enrollment: 16 (estimated)

## Conditions studied

- B-ALL

## Interventions

- **BIOLOGICAL:** ThisCART19A

## Key facts

- **NCT ID:** NCT05350852
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-18
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2022-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05350852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05350852, "Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALL". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05350852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*